Recent Updates
Recently added Catalysts
MOBI Positive Sentiment

Mobia Medical to Participate in the 8th Annual Wolfe Research Healthcare Conference

Key Takeaway: Mobia Medical, Inc. will participate in the 8th Annual Wolfe Research Healthcare Conference on November 10, 2026. Management will host a fireside chat and one-on-one investor meetings. The company focuses on stroke recovery through its FDA-approved Vivistim® Paired VNS™ System, aimed at improving motor function in stroke survivors.

Market Sentiment Analysis

POSITIVE FACTORS

  • Mobia Medical is redefining stroke recovery.
  • The Vivistim® Paired VNS™ System is FDA-approved.
  • Management will engage with investors at a major conference.

Full Press Release Details

AUSTIN, Texas, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that members of management will participate in a fireside chat and host one-on-one investor meetings at the upcoming 8th Annual Wolfe Research Healthcare Conference in New York. The fireside chat will take place on Tuesday, November 10, 2026, at 12:20 p.m. Pacific Time / 3:20 p.m. Eastern Time.
Event: 8th Annual Wolfe Research Healthcare Conference Date: Tuesday, November 10, 2026 Time: 12:20 p.m. PT / 3:20 p.m. ET Webcast: https://event.summitcast.com/view/NUQKc6DhSdr7nD3Q2zrrqL/Y2MXruawnsXcnfxYAbBzJ6
A live and archived version of the fireside chat will be available via the News & Events page of the investor section of Mobia Medical’s website.

About Mobia Medical, Inc.

Mobia Medical, Inc. is a medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim® Paired VNS™ System is the first and only clinically validated, FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Therapy with the Vivistim® Paired VNS™ System combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. Mobia Medical is mobilizing patients, providers, and care partners to establish a better way forward in stroke care.

Investor Relations Contact Louisa Smith Gilmartin Group, LLC investors@mobia.com

Media Inquiries Contact Terri Clevenger tclevenger@waterhousebrands.com

Frequently Asked Questions

When is Mobia Medical participating in the conference?

Mobia Medical will participate on November 10, 2026.

What is the Vivistim® Paired VNS™ System?

It is an FDA-approved device for improving motor function in stroke survivors.

Where can I watch the fireside chat?

The chat will be available on Mobia Medical's investor website.

What time is the fireside chat scheduled?

The chat is scheduled for 12:20 p.m. PT / 3:20 p.m. ET.

Last updated: Nov 3, 2026